Institutional Ownership
Neumora Therapeutics Inc.
CUSIP 640979100COMNMRAQ1 2026
13D / 13G Filings
15
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
23.2%
Max % of class reported
Institutional Holders
109
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
15 filings · latest Feb 19, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 19, 2026 | Invus Public Equities, L.P. | 13G | 5.4% | 9.00M | SEC |
| 2 | Feb 17, 2026 | K2 Healthventures Equity Trust LLC | 13G/A | 5.0% | 9.00M | SEC |
| 3 | Oct 29, 2025 | Arch Venture Fund Vii, L.P. | 13D/A | 20.7% | — | SEC |
| 4 | Aug 11, 2025 | K2 Healthventures Equity Trust LLC | 13G | 6.6% | 92.03T | SEC |
| 5 | May 12, 2025 | Fmr LLC | 13G/A | 2.2% | 3.50M | SEC |
| 6 | Feb 13, 2025 | Paul L Berns | 13G/A | 5.1% | 8.23M | SEC |
| 7 | Nov 22, 2024 | Arch Venture Fund Xii, L.P. | 13D/A | 19.8% | 31.93M | SEC |
| 8 | Nov 12, 2024 | Softbank Group Corp. | 13G | 4.7% | 7.55M | SEC |
| 9 | Jul 8, 2024 | Fmr LLC | 13G | 5.4% | 8.62M | SEC |
| 10 | Jul 8, 2024 | Fmr LLC | 13G | 5.4% | 8.62M | SEC |
5 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Neumora Therapeutics Inc..
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Siren, L.L.C. | 8.50M | $16.57M |
| 2 | Softbank Group Corp. | 6.09M | $11.88M |
| 3 | Perceptive Advisors LLC | 5.10M | $9.95M |
| 4 | Mic Capital Management Uk LLP | 4.46M | $8.70M |
| 5 | Fmr LLC | 3.50M | $6.82M |
| 6 | Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust | 3.31M | $6.45M |
| 7 | Millennium Management LLC | 2.75M | $5.37M |
| 8 | Iconiq Capital, LLC | 2.56M | $4.99M |
| 9 | Lunate Capital Ltd | 2.12M | $4.14M |
| 10 | Blackrock, Inc. | 2.05M | $4.01M |